58 related articles for article (PubMed ID: 36376131)
1. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.
Barrington SF; Kluge R
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):97-110. PubMed ID: 28411336
[TBL] [Abstract][Full Text] [Related]
2. Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma.
Calabretta E; di Trani M; Corrado F; Sollini M; Cristaldi V; Marino F; Terzi di Bergamo L; Bruscaggin A; Pirosa MC; Bramanti S; Chiti A; Rossi D; Carlo-Stella C
Br J Haematol; 2024 Feb; 204(2):514-524. PubMed ID: 37853658
[TBL] [Abstract][Full Text] [Related]
3. Application of interim PET-CT in first-line treatment decision-making for lymphoma.
Huang L; Zhao Y; He J
J Zhejiang Univ Sci B; 2023 Oct; 24(10):905-921. PubMed ID: 37752092
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
Zijlstra JM; Burggraaff CN; Kersten MJ; Barrington SF;
Haematologica; 2016 Nov; 101(11):1279-1283. PubMed ID: 27799345
[No Abstract] [Full Text] [Related]
5. PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L; Bezzi D; Nanni C; Paccagnella A; Farina A; Broccoli A; Casadei B; Zinzani PL; Fanti S
Semin Nucl Med; 2023 May; 53(3):320-351. PubMed ID: 36522191
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in
Jamalipour Soufi G; Hekmatnia A; Hekmatnia F; Zarei AP; Shafieyoon S; Azizollahi S; Ghazanfari Hashemi M; Riahi F
Am J Nucl Med Mol Imaging; 2024; 14(2):97-109. PubMed ID: 38737646
[TBL] [Abstract][Full Text] [Related]
7. Approach to Imaging of Mediastinal Masses.
Ahuja J; Strange CD; Agrawal R; Erasmus LT; Truong MT
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37891992
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of whole-body dynamic
Yin J; Wang H; Zhu G; Chen N; Khan MI; Zhao Y
Heliyon; 2023 Sep; 9(9):e19749. PubMed ID: 37809527
[TBL] [Abstract][Full Text] [Related]
9. Interim PET in follicular lymphoma: more patience, please.
Procházka V
Ann Hematol; 2023 Jul; 102(7):1953-1954. PubMed ID: 37087410
[No Abstract] [Full Text] [Related]
10. Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
de Oliveira Costa R; Hallack Neto A; Siqueira S; Lage LA; de Paula HM; Coutinho AM; Pereira J
Nucl Med Commun; 2016 Oct; 37(10):1095-101. PubMed ID: 27281359
[TBL] [Abstract][Full Text] [Related]
11. Interim FDG-PET Imaging in Lymphoma.
Gallamini A; Zwarthoed C
Semin Nucl Med; 2018 Jan; 48(1):17-27. PubMed ID: 29195613
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT in the management of lymphomas: current status and future directions.
El-Galaly TC; Villa D; Gormsen LC; Baech J; Lo A; Cheah CY
J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234
[TBL] [Abstract][Full Text] [Related]
13. Interim FDG-PET/CT for Response Assessment of Lymphoma.
Zeman MN; Akin EA; Merryman RW; Jacene HA
Semin Nucl Med; 2023 May; 53(3):371-388. PubMed ID: 36376131
[TBL] [Abstract][Full Text] [Related]
14. CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
Ganeshan B; Miles KA; Babikir S; Shortman R; Afaq A; Ardeshna KM; Groves AM; Kayani I
Eur Radiol; 2017 Mar; 27(3):1012-1020. PubMed ID: 27380902
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of metabolic criteria in the prognostic assessment in patients with lymphoma. A multicentre study.
Del Puig Cózar-Santiago M; García-Garzón JR; Moragas-Freixa M; Soler-Peter M; Bassa Massanas P; Sánchez-Delgado M; Sanchez-Jurado R; Aguilar-Barrios JE; Sanz-Llorens R; Ferrer-Rebolleda J
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):304-311. PubMed ID: 28483373
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
